# Ernexa Therapeutics Inc.: Form S-1, filed Apr 17, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1
- Filed: 2023-04-17
- Accepted by EDGAR: Apr 14, 2023, 21:29 ET
- Period: not reported
- Accession: 0001140361-23-018529
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036123018529/ny20008758x1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036123018529/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036123018529/ny20008758x1_s1.htm

Filed Apr 17, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-018529. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.